These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25471842)

  • 1. Digging into 'the rabbit-hole' of the extracellular matrix.
    Burgstaller G
    Respiration; 2015; 89(1):15-6. PubMed ID: 25471842
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of extracellular matrix quality in pulmonary fibrosis.
    Kristensen JH; Karsdal MA; Genovese F; Johnson S; Svensson B; Jacobsen S; Hägglund P; Leeming DJ
    Respiration; 2014; 88(6):487-99. PubMed ID: 25359084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting impairment of diffusing capacity for Chinese patients with lung fibrosis.
    Leung SK; Lam FM; Yew WW; Wong PC
    Respirology; 2008 Nov; 13(6):929-30. PubMed ID: 18811893
    [No Abstract]   [Full Text] [Related]  

  • 4. FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.
    Staab-Weijnitz CA; Fernandez IE; Knüppel L; Maul J; Heinzelmann K; Juan-Guardela BM; Hennen E; Preissler G; Winter H; Neurohr C; Hatz R; Lindner M; Behr J; Kaminski N; Eickelberg O
    Am J Respir Crit Care Med; 2015 Aug; 192(4):455-67. PubMed ID: 26039104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways.
    Blaauboer ME; Emson CL; Verschuren L; van Erk M; Turner SM; Everts V; Hanemaaijer R; Stoop R
    Matrix Biol; 2013; 32(7-8):424-31. PubMed ID: 23648810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic pulmonary fibrosis--new insights.
    Verma S; Slutsky AS
    N Engl J Med; 2007 Mar; 356(13):1370-2. PubMed ID: 17392309
    [No Abstract]   [Full Text] [Related]  

  • 7. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis.
    García-Sancho C; Buendía-Roldán I; Fernández-Plata MR; Navarro C; Pérez-Padilla R; Vargas MH; Loyd JE; Selman M
    Respir Med; 2011 Dec; 105(12):1902-7. PubMed ID: 21917441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts.
    Hetzel M; Bachem M; Anders D; Trischler G; Faehling M
    Lung; 2005; 183(4):225-37. PubMed ID: 16211459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic pulmonary fibrosis.
    Hoo ZH; Whyte MK
    Thorax; 2012 Aug; 67(8):742-6. PubMed ID: 21697287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in idiopathic pulmonary fibrosis.
    Piguet PF
    Am J Respir Crit Care Med; 2003 Apr; 167(7):1037; author reply 1037. PubMed ID: 12663344
    [No Abstract]   [Full Text] [Related]  

  • 11. Spaceflight modulates expression of extracellular matrix, adhesion, and profibrotic molecules in mouse lung.
    Tian J; Pecaut MJ; Slater JM; Gridley DS
    J Appl Physiol (1985); 2010 Jan; 108(1):162-71. PubMed ID: 19850731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis.
    Hosoda C; Baba T; Hagiwara E; Ito H; Matsuo N; Kitamura H; Iwasawa T; Okudela K; Takemura T; Ogura T
    Respirology; 2016 Jul; 21(5):920-6. PubMed ID: 26994375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis.
    Gauldie J
    Am J Respir Crit Care Med; 2002 May; 165(9):1205-6. PubMed ID: 11991866
    [No Abstract]   [Full Text] [Related]  

  • 14. New pharmacological strategies for the treatment of pulmonary fibrosis.
    Gogali A; Wells AU
    Ther Adv Respir Dis; 2010 Dec; 4(6):353-66. PubMed ID: 20864457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis.
    Park AM; Kanai K; Itoh T; Sato T; Tsukui T; Inagaki Y; Selman M; Matsushima K; Yoshie O
    PLoS One; 2016; 11(2):e0148998. PubMed ID: 26859835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Faner R; Rojas M; Macnee W; Agustí A
    Am J Respir Crit Care Med; 2012 Aug; 186(4):306-13. PubMed ID: 22582162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung extracellular matrix and redox regulation.
    Watson WH; Ritzenthaler JD; Roman J
    Redox Biol; 2016 Aug; 8():305-15. PubMed ID: 26938939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic pulmonary fibrosis.
    King TE; Pardo A; Selman M
    Lancet; 2011 Dec; 378(9807):1949-61. PubMed ID: 21719092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy endpoints for idiopathic pulmonary fibrosis trials.
    Richeldi L
    Lancet Respir Med; 2015 May; 3(5):335-7. PubMed ID: 25890799
    [No Abstract]   [Full Text] [Related]  

  • 20. Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis.
    Bargagli E; Penza F; Bianchi N; Olivieri C; Bennett D; Prasse A; Rottoli P
    Respir Physiol Neurobiol; 2009 Feb; 165(2-3):119-20; author reply 121-2. PubMed ID: 19026768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.